MacroGenics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MacroGenics and other ETFs, options, and stocks.About MGNX
MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases.
MGNX Key Statistics
Stock Snapshot
As of today, MacroGenics(MGNX) shares are valued at $4.50. The company's market cap stands at 286.99M, with a P/E ratio of -4.07.
On 2026-05-19, MacroGenics(MGNX) stock traded between a low of $4.33 and a high of $4.64. Shares are currently priced at $4.50, which is +3.9% above the low and -2.9% below the high.
The MacroGenics(MGNX)'s current trading volume is 1.7M, compared to an average daily volume of 2.33M.
In the last year, MacroGenics(MGNX) shares hit a 52-week high of $4.64 and a 52-week low of $1.19.
In the last year, MacroGenics(MGNX) shares hit a 52-week high of $4.64 and a 52-week low of $1.19.
MGNX News
Reports Q1 revenue $20.78M, consensus $15.24M. “We are very pleased to report a strong start to the year, building on the momentum generated in 2025. These resu...
Analyst ratings
57%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.